Four of the eight people appointed by Health Secretary Robert F. Kennedy Jr. to an influential health panel in September own stock in companies that make drugs and other products affected by the group’s decisions, according to documents reviewed by The New York Times.
The investments were described in conflict-of-interest waivers that gave the members permission to serve on the panel, the United States Preventive Services Task Force. The Times obtained the waivers through a public records request.
The task force evaluates evidence for services such as colonoscopies, HIV prevention medications, depression screening and more, and its recommendations both inform doctors’ decisions and determine what insurers must pay for.…